Abivax SA Sponsored ADR (ABVX)
NASDAQ:ABVX
Total Valuation
Abivax SA Sponsored ADR has a market cap or net worth of $8.15B. The enterprise value is $7.10B.
Market Cap$8.15B
Enterprise Value$7.10B
Share Statistics
Abivax SA Sponsored ADR has 79,167,435 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding79,167,435
Owned by Insiders―
Owned by Institutions42.38%
Financial Efficiency
Abivax SA Sponsored ADR’s return on equity (ROE) is -0.71 and return on invested capital (ROIC) is -46.08%.
Return on Equity (ROE)-0.71
Return on Assets (ROA)-0.55
Return on Invested Capital (ROIC)-46.08%
Return on Capital Employed (ROCE)-0.46
Revenue Per Employee0.00
Profits Per Employee-4.68M
Employee Count69
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Abivax SA Sponsored ADR is ―. Abivax SA Sponsored ADR’s PEG ratio is -0.37.
PE Ratio―
PS Ratio0.00
PB Ratio17.54
Price to Fair Value17.54
Price to FCF-51.21
Price to Operating Cash Flow-41.30
PEG Ratio-0.37
Income Statement
In the last 12 months, Abivax SA Sponsored ADR had revenue of 0.00 and earned -322.84M in profits. Earnings per share was -4.65.
Revenue0.00
Gross Profit-1.03M
Operating Income-240.73M
Pretax Income-320.16M
Net Income-322.84M
EBITDA-239.70M
Earnings Per Share (EPS)-4.65
Cash Flow
In the last 12 months, operating cash flow was -135.51M and capital expenditures -265.00K, giving a free cash flow of -135.98M billion.
Operating Cash Flow-135.51M
Free Cash Flow-135.98M
Free Cash Flow per Share-1.72
Dividends & Yields
Abivax SA Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.61
52-Week Price Change1539.52%
50-Day Moving Average118.22
200-Day Moving Average90.00
Relative Strength Index (RSI)34.38
Average Volume (3m)976.51K
Important Dates
Abivax SA Sponsored ADR upcoming earnings date is Jun 8, 2026, During Market Hours (Confirmed).
Last Earnings DateMar 23, 2026
Next Earnings DateJun 8, 2026
Ex-Dividend Date―
Financial Position
Abivax SA Sponsored ADR as a current ratio of 8.75, with Debt / Equity ratio of -204.45%
Current Ratio8.75
Quick Ratio8.75
Debt to Market Cap<0.01
Net Debt to EBITDA2.02
Interest Coverage Ratio-8.79
Taxes
In the past 12 months, Abivax SA Sponsored ADR has paid 2.68M in taxes.
Income Tax2.68M
Effective Tax Rate>-0.01
Enterprise Valuation
Abivax SA Sponsored ADR EV to EBITDA ratio is -31.27, with an EV/FCF ratio of -48.10.
EV to Sales0.00
EV to EBITDA-31.27
EV to Free Cash Flow-48.10
EV to Operating Cash Flow-48.14
Balance Sheet
Abivax SA Sponsored ADR has $60.95M in cash and marketable securities with $84.57M in debt, giving a net cash position of -$23.63M billion.
Cash & Marketable Securities$60.95M
Total Debt$84.57M
Net Cash-$23.63M
Net Cash Per Share-$0.30
Tangible Book Value Per Share$6.18
Margins
Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin100.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Abivax SA Sponsored ADR is $151.44, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$151.44
Price Target Upside47.79% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast―
EPS Growth Forecast18.47%